These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6346025)

  • 1. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. II. Isolation and characterization of the protective moiety in the dialyzable factor.
    Kita E; Tsukao N; Kitajima S; Takahashi S; Kashiba S
    Microbiol Immunol; 1983; 27(2):117-30. PubMed ID: 6346025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
    Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
    Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors.
    Kita E; Yasui K; Yasui K; Matsuda Y; Matsuda K; Kashiba S
    Microbiol Immunol; 1984; 28(7):807-20. PubMed ID: 6436650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.
    Eisenstein TK
    Infect Immun; 1975 Aug; 12(2):364-77. PubMed ID: 51007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
    Johnson W
    Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.
    Hoops P; Prather NE; Berry J; Ravel JM
    Infect Immun; 1976 Apr; 13(4):1184-92. PubMed ID: 776831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection.
    Kita E; Kashiba S
    Immunology; 1983 Nov; 50(3):369-76. PubMed ID: 6195095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.
    Kita E; Emoto M; Katsui N; Nishi K; Yasui K; Yasui K; Kashiba S
    Immunology; 1987 Oct; 62(2):235-40. PubMed ID: 2445665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective ability of Salmonella ribosomal protein and RNA in inbred mice.
    Misfeldt ML; Johnson W
    Infect Immun; 1978 Jul; 21(1):286-91. PubMed ID: 30697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
    Lin JH; Berry LJ
    J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.
    Venneman MR
    Infect Immun; 1972 Mar; 5(3):269-82. PubMed ID: 4564556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
    Venneman MR; Bigley NJ
    J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection.
    Kita E; Oku D; Nishikawa F; Emoto M; Yasui K; Kashiba S
    FEMS Microbiol Immunol; 1991 Aug; 3(4):229-39. PubMed ID: 1931135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
    Nickol AD; Bonventre PF
    J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial ribosomal vaccines.
    Gregory RL
    Rev Infect Dis; 1986; 8(2):208-17. PubMed ID: 3518022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium.
    Misfeldt ML; Johnson W
    Infect Immun; 1979 Jun; 24(3):808-16. PubMed ID: 381202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
    Venneman MR; Berry LJ
    Infect Immun; 1971 Oct; 4(4):374-80. PubMed ID: 4949497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.
    Kita E; Matsuda Y; Matsuda K; Kashiba S
    Cell Immunol; 1984 Sep; 87(2):528-37. PubMed ID: 6380767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].
    Schlecht S; Westphal O
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.
    Johnson W
    Infect Immun; 1973 Sep; 8(3):395-400. PubMed ID: 4199718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.